About Finecure pharma
Finecure pharma is a company based in Ahmedabad (India) founded in 2005. Finecure pharma has raised $131.47 thousand across 1 funding round from investors including Vikas Agrawal, Ramavtar Prasad and Rupa Agrawal. The company has 454 employees as of March 07, 2025. Finecure pharma offers products and services including Antibiotics and Anti-Infectives and Anti-Asthmatics and Anti-Allergic Drugs.
- Headquarter Ahmedabad, India
- Employees 454 as on 07 Mar, 2025
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Finecure Pharmaceuticals Limited
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$25.92 M (USD)8.25as on Mar 31, 2024
-
Net Profit
$983.31 K (USD)-25.87as on Mar 31, 2024
-
EBITDA
$2.57 M (USD)-14.35as on Mar 31, 2024
-
Total Equity Funding
$131.47 K (USD)
in 1 rounds
-
Latest Funding Round
$131.47 K (USD), Seed
Mar 02, 2007
-
Investors
mihiragencies
& 20 more
-
Employee Count
454
as on Mar 07, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Finecure pharma
Finecure pharma offers a comprehensive portfolio of products and services, including Antibiotics and Anti-Infectives and Anti-Asthmatics and Anti-Allergic Drugs.
Products are provided for treating infections, including antibiotics and antimalarials that act selectively on disease causes
Drugs are designed for addressing respiratory diseases such as asthma and allergic rhinitis
Funding Insights of Finecure pharma
Finecure pharma has successfully raised a total of $131.47K through 1 strategic funding round. The most recent funding activity was a Seed round of $131.47 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Finecure pharma
Finecure pharma has secured backing from 21 investors, including angel and institutional investors. Prominent investors backing the company include Vikas Agrawal, Ramavtar Prasad and Rupa Agrawal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
VA
Vikas Agrawal |
Angel investor, ex-entrepreneur, focused on tech startups in India.
|
Locked | Locked | Locked |
|
RP
Ramavtar Prasad |
-
|
Locked | Locked | Locked |
Investor details for Finecure pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Finecure pharma
Investment portfolio details for Finecure pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Finecure pharma
Detailed financials for Finecure pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Finecure Pharma Comparisons
Peer comparison for Finecure pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Finecure pharma
Detailed competitors of Finecure pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Finecure Pharma
Complete news archive for Finecure pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Finecure pharma
Finecure pharma was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Finecure pharma is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Vishal Rajgarhia is the current CEO of Finecure pharma.
Finecure pharma is a funded company, having raised a total of $131.47K across 1 funding round to date.
As of Mar 07, 2025, the latest employee count at Finecure pharma is 454.
Annual revenue of Finecure pharma is $25.92M as on Mar 31, 2024.
Founded in 2005 in Ahmedabad, India, operations are focused on the pharmaceutical sector, where formulations in oral dosage forms and injections are produced for niche therapeutic segments including cardiovascular, diabetology, neurology, and anti-infectives. Certifications such as WHO-GMP are held by manufacturing plants. A dedicated division is maintained for innovative medicines targeting cardiovascular and diabetology treatments, with products extending to gastrointestinal, dermatology, pain management, and OTC areas.
Finecure pharma offers Antibiotics and Anti-Infectives and Anti-Asthmatics and Anti-Allergic Drugs.
Finecure pharma has 21 investors. Key investors include Vikas Agrawal, Ramavtar Prasad, Rupa Agrawal, Satyabhamadevi, and mihiragencies.
The valuation of Finecure pharma is $444.13K as of Mar 2007.